A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans

Detalhes bibliográficos
Autor(a) principal: Zambom, Carolina R. [UNESP]
Data de Publicação: 2019
Outros Autores: Fonseca, Fauller H. da [UNESP], Crusca Jr, Edson [UNESP], Silva, Patricia B. da [UNESP], Pavan, Fernando R. [UNESP], Chorilli, Marius [UNESP], Garrido, Saulo S. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.3389/fmicb.2019.01667
http://hdl.handle.net/11449/185957
Resumo: Currently 75-88% of fungal infections are caused by Candida species, and Candida albicans is the main microorganism that causes these infections, especially oral candidiasis. An option for treatment involves the use of the antifungal peptide Histatin 5 (Hst 5), which is naturally found in human saliva but undergoes rapid degradation when present in the oral cavity, its site of action. For this reason, it is important to develop a way of applying this peptide to the oral lesions, which promotes the gradual release of the peptide. In the present study, we have evaluated the development of liposomes of different lipid compositions, loaded with the peptide as a way to promote its release slowly and gradually, preserving its antifungal potential. For this, the peptide 0WHistatin 5, an analog of the peptide Hst 5, was synthesized, which contains the amino acid tryptophan in its sequence. The solid phase synthesis method was used, followed by cleavage and purification. The liposomes were produced by thin film hydration technique in three different lipid compositions, F1, F2, and F3 and were submitted to an extrusion and sonication process to standardize the size and study the best technique for their production. The liposomes were characterized by dynamic light scattering, and tests were performed to determine the encapsulation efficiency, release kinetics, stability, and evaluation of antifungal activity. The extruded liposomes presented average size in the range of 100 nm, while sonicated liposomes presented a smaller size in the range of 80 nm. The encapsulation efficiency was higher for the sonicated liposomes, being 34.5% for F1. The sonicated F3 presented better stability when stored for 60 days at 4 degrees C. The liposomes showed the ability to release the peptide for the total time of 96 h, with the first peak after 5 h, and a further increase of the released after 30 h. Time-kill assay showed that the liposomes were able to control yeast growth for 72 h. The data suggest that the liposomes loaded with 0WHistatin 5 maintained the action of the peptide and were able to limit the growth of C. albicans, being a suitable system for use in the treatment of oral candidiasis.
id UNSP_e34e9d97dfa60939d3c5c5deb14c4295
oai_identifier_str oai:repositorio.unesp.br:11449/185957
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicansantifungal systemoral candidiasisCandida albicansHistatin 5liposomesCurrently 75-88% of fungal infections are caused by Candida species, and Candida albicans is the main microorganism that causes these infections, especially oral candidiasis. An option for treatment involves the use of the antifungal peptide Histatin 5 (Hst 5), which is naturally found in human saliva but undergoes rapid degradation when present in the oral cavity, its site of action. For this reason, it is important to develop a way of applying this peptide to the oral lesions, which promotes the gradual release of the peptide. In the present study, we have evaluated the development of liposomes of different lipid compositions, loaded with the peptide as a way to promote its release slowly and gradually, preserving its antifungal potential. For this, the peptide 0WHistatin 5, an analog of the peptide Hst 5, was synthesized, which contains the amino acid tryptophan in its sequence. The solid phase synthesis method was used, followed by cleavage and purification. The liposomes were produced by thin film hydration technique in three different lipid compositions, F1, F2, and F3 and were submitted to an extrusion and sonication process to standardize the size and study the best technique for their production. The liposomes were characterized by dynamic light scattering, and tests were performed to determine the encapsulation efficiency, release kinetics, stability, and evaluation of antifungal activity. The extruded liposomes presented average size in the range of 100 nm, while sonicated liposomes presented a smaller size in the range of 80 nm. The encapsulation efficiency was higher for the sonicated liposomes, being 34.5% for F1. The sonicated F3 presented better stability when stored for 60 days at 4 degrees C. The liposomes showed the ability to release the peptide for the total time of 96 h, with the first peak after 5 h, and a further increase of the released after 30 h. Time-kill assay showed that the liposomes were able to control yeast growth for 72 h. The data suggest that the liposomes loaded with 0WHistatin 5 maintained the action of the peptide and were able to limit the growth of C. albicans, being a suitable system for use in the treatment of oral candidiasis.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)UNESP Sao Paulo State Univ, Inst Chem, Dept Biochem & Chem Technol, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Drugs & Med, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Biol Sci, Araraquara, BrazilUNESP Sao Paulo State Univ, Inst Chem, Dept Biochem & Chem Technol, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Drugs & Med, Araraquara, BrazilUNESP Sao Paulo State Univ, Sch Pharmaceut Sci Araraquara, Dept Biol Sci, Araraquara, BrazilFAPESP: 2013/19370-2FAPESP: 2018/03018-1Frontiers Media SaUniversidade Estadual Paulista (Unesp)Zambom, Carolina R. [UNESP]Fonseca, Fauller H. da [UNESP]Crusca Jr, Edson [UNESP]Silva, Patricia B. da [UNESP]Pavan, Fernando R. [UNESP]Chorilli, Marius [UNESP]Garrido, Saulo S. [UNESP]2019-10-04T12:40:01Z2019-10-04T12:40:01Z2019-07-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article11http://dx.doi.org/10.3389/fmicb.2019.01667Frontiers In Microbiology. Lausanne: Frontiers Media Sa, v. 10, 11 p., 2019.1664-302Xhttp://hdl.handle.net/11449/18595710.3389/fmicb.2019.01667WOS:000477791800001Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengFrontiers In Microbiologyinfo:eu-repo/semantics/openAccess2024-06-24T13:46:01Zoai:repositorio.unesp.br:11449/185957Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T20:15:15.536732Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
title A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
spellingShingle A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
Zambom, Carolina R. [UNESP]
antifungal system
oral candidiasis
Candida albicans
Histatin 5
liposomes
title_short A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
title_full A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
title_fullStr A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
title_full_unstemmed A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
title_sort A Novel Antifungal System With Potential for Prolonged Delivery of Histatin 5 to Limit Growth of Candida albicans
author Zambom, Carolina R. [UNESP]
author_facet Zambom, Carolina R. [UNESP]
Fonseca, Fauller H. da [UNESP]
Crusca Jr, Edson [UNESP]
Silva, Patricia B. da [UNESP]
Pavan, Fernando R. [UNESP]
Chorilli, Marius [UNESP]
Garrido, Saulo S. [UNESP]
author_role author
author2 Fonseca, Fauller H. da [UNESP]
Crusca Jr, Edson [UNESP]
Silva, Patricia B. da [UNESP]
Pavan, Fernando R. [UNESP]
Chorilli, Marius [UNESP]
Garrido, Saulo S. [UNESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Zambom, Carolina R. [UNESP]
Fonseca, Fauller H. da [UNESP]
Crusca Jr, Edson [UNESP]
Silva, Patricia B. da [UNESP]
Pavan, Fernando R. [UNESP]
Chorilli, Marius [UNESP]
Garrido, Saulo S. [UNESP]
dc.subject.por.fl_str_mv antifungal system
oral candidiasis
Candida albicans
Histatin 5
liposomes
topic antifungal system
oral candidiasis
Candida albicans
Histatin 5
liposomes
description Currently 75-88% of fungal infections are caused by Candida species, and Candida albicans is the main microorganism that causes these infections, especially oral candidiasis. An option for treatment involves the use of the antifungal peptide Histatin 5 (Hst 5), which is naturally found in human saliva but undergoes rapid degradation when present in the oral cavity, its site of action. For this reason, it is important to develop a way of applying this peptide to the oral lesions, which promotes the gradual release of the peptide. In the present study, we have evaluated the development of liposomes of different lipid compositions, loaded with the peptide as a way to promote its release slowly and gradually, preserving its antifungal potential. For this, the peptide 0WHistatin 5, an analog of the peptide Hst 5, was synthesized, which contains the amino acid tryptophan in its sequence. The solid phase synthesis method was used, followed by cleavage and purification. The liposomes were produced by thin film hydration technique in three different lipid compositions, F1, F2, and F3 and were submitted to an extrusion and sonication process to standardize the size and study the best technique for their production. The liposomes were characterized by dynamic light scattering, and tests were performed to determine the encapsulation efficiency, release kinetics, stability, and evaluation of antifungal activity. The extruded liposomes presented average size in the range of 100 nm, while sonicated liposomes presented a smaller size in the range of 80 nm. The encapsulation efficiency was higher for the sonicated liposomes, being 34.5% for F1. The sonicated F3 presented better stability when stored for 60 days at 4 degrees C. The liposomes showed the ability to release the peptide for the total time of 96 h, with the first peak after 5 h, and a further increase of the released after 30 h. Time-kill assay showed that the liposomes were able to control yeast growth for 72 h. The data suggest that the liposomes loaded with 0WHistatin 5 maintained the action of the peptide and were able to limit the growth of C. albicans, being a suitable system for use in the treatment of oral candidiasis.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-04T12:40:01Z
2019-10-04T12:40:01Z
2019-07-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3389/fmicb.2019.01667
Frontiers In Microbiology. Lausanne: Frontiers Media Sa, v. 10, 11 p., 2019.
1664-302X
http://hdl.handle.net/11449/185957
10.3389/fmicb.2019.01667
WOS:000477791800001
url http://dx.doi.org/10.3389/fmicb.2019.01667
http://hdl.handle.net/11449/185957
identifier_str_mv Frontiers In Microbiology. Lausanne: Frontiers Media Sa, v. 10, 11 p., 2019.
1664-302X
10.3389/fmicb.2019.01667
WOS:000477791800001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Frontiers In Microbiology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 11
dc.publisher.none.fl_str_mv Frontiers Media Sa
publisher.none.fl_str_mv Frontiers Media Sa
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129179599765504